These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 2899362)

  • 1. Immunosuppression of graft rejection with idarubicin-monoclonal antibody conjugates by elimination of T cell subsets in vivo.
    Smyth MJ; Pietersz GA; McKenzie IF
    Transplantation; 1988 Jul; 46(1):126-31. PubMed ID: 2899362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of idarubicin monoclonal antibody treatment of first-set rejection of murine skin allografts.
    Smyth MJ; McKenzie IF; Pietersz GA
    Transplantation; 1989 Jul; 48(1):77-9. PubMed ID: 2665240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunochemotherapy of a murine thymoma with the use of idarubicin monoclonal antibody conjugates.
    Pietersz GA; Smyth MJ; McKenzie IF
    Cancer Res; 1988 Feb; 48(4):926-31. PubMed ID: 3422182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that an anthracycline-anti-CD8 immunoconjugate, idarubicin-anti-Ly-2.1, prolongs heart allograft survival in mice.
    Mottram PL; Pietersz GA; Smyth MJ; Purcell LJ; Clunie GJ; McKenzie IF
    Transplantation; 1993 Mar; 55(3):484-90. PubMed ID: 8456465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4-/CD8-T cells: amplification in spleens of mice following in vivo treatment with monoclonal antibody anti-L3T4.
    Ermak TH; Steger HJ
    Eur J Immunol; 1988 Feb; 18(2):231-5. PubMed ID: 2894995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-T cell-specific immunoconjugates in mice: in vivo effects.
    Mottram PL; Smyth M; Pietersz GA; Clunie GJ; McKenzie IF
    Transplant Proc; 1989 Oct; 21(5):3757-8. PubMed ID: 2573184
    [No Abstract]   [Full Text] [Related]  

  • 7. Generation of L3T4-/Ly-2- T cells in Peyer's patches of mice treated with monoclonal antibody against helper T cells.
    Ermak TH; Steger HJ; Heyworth MF
    Immunol Lett; 1988 Mar; 17(3):205-10. PubMed ID: 2897329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Murine cardiac allograft survival following treatment of recipients with monoclonal anti-L3T4 or Ly-2 antibodies.
    Mottram PL; Wheelahan J; McKenzie IF; Clunie GJ
    Transplant Proc; 1987 Apr; 19(2):2898-901. PubMed ID: 3105127
    [No Abstract]   [Full Text] [Related]  

  • 9. Deletion of graft reactive cells by idarubicin-anti-CD8 (Ly-2.1) immunoconjugate: studies in the mouse heart graft model.
    Mottram PL; Pietersz GA; Purcell LJ; Krauer K; Clunie GJ; McKenzie IF
    Transplant Proc; 1991 Feb; 23(1 Pt 1):499-500. PubMed ID: 1899311
    [No Abstract]   [Full Text] [Related]  

  • 10. Importance of Lyt-2+ T-cells in the resistance of melphalan-cured MOPC-315 tumor bearers to a challenge with MOPC-315 tumor cells.
    Barker E; Mokyr MB
    Cancer Res; 1988 Sep; 48(17):4834-42. PubMed ID: 3261626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of early stages of T lymphocyte development in the thymus cortex and medulla.
    Scollay R; Shortman K
    J Immunol; 1985 Jun; 134(6):3632-42. PubMed ID: 3886788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of autoreactive L3T4+ T cells from double-negative (L3T4-/Ly-2-) Thy-1+ spleen cells of normal mice.
    Reimann J; Bellan A; Conradt P
    Eur J Immunol; 1988 Jul; 18(7):989-99. PubMed ID: 2900151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antilymphocytic antibodies and bone marrow transplantation. XI. Evidence that reduced Thy-1 expression in Thy-1.1 mice prevents suppression of graft-versus-host disease with anti-Thy-1 monoclonal antibodies.
    Mysliwietz J; Thierfelder S; Hoffmann-Fezer G; Kummer U
    Transplantation; 1990 Apr; 49(4):749-55. PubMed ID: 1970200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor activity of idarubicin-monoclonal antibody conjugates in a disseminated thymic lymphoma model.
    Smyth MJ; Bogdanovski M; McKenzie IF; Pietersz GA
    Cancer Res; 1991 Jan; 51(1):310-7. PubMed ID: 1988093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of T4+ and Ly-2+ cells in skin graft rejection in the mouse.
    Wheelahan J; McKenzie IF
    Transplantation; 1987 Aug; 44(2):273-80. PubMed ID: 3114924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppression by anti-CD8 (Ly-2.1) MAb conjugated to idarubicin: studies in the mouse heart graft model.
    Mottram PL; Pietersz GA; Purcell LJ; Clunie GJ; McKenzie IF
    Transplant Proc; 1990 Oct; 22(5):2111-2. PubMed ID: 2120812
    [No Abstract]   [Full Text] [Related]  

  • 17. Anti-T cell monoclonal antibodies for in vivo treatment of cardiac allograft rejection in mice.
    Mottram PL; Smyth M; Pietersz GA; Clunie GJ; McKenzie IF
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1020-1. PubMed ID: 2650063
    [No Abstract]   [Full Text] [Related]  

  • 18. Preventive effect of monoclonal anti-L3T4 antibody on development of diabetes in NOD mice.
    Koike T; Itoh Y; Ishii T; Ito I; Takabayashi K; Maruyama N; Tomioka H; Yoshida S
    Diabetes; 1987 Apr; 36(4):539-41. PubMed ID: 3102302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmune syndrome after induction of neonatal tolerance to alloantigens: effects of in vivo treatment with anti-T cell subset monoclonal antibodies.
    Merino J; Schurmans S; Luzuy S; Izui S; Vassalli P; Lambert PH
    J Immunol; 1987 Sep; 139(5):1426-31. PubMed ID: 3114366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of anti-L3T4 and anti-Lyt 2 monoclonal antibodies on murine cardiac allograft rejection.
    Madsen JC; Wood KJ; Morris PJ
    Transplant Proc; 1987 Oct; 19(5):3991-2. PubMed ID: 3313979
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.